Table 7.
Survival status.
| Diagnosis | Alive with disease | Alive without disease | Dead with disease |
|---|---|---|---|
| Psoriasis | 45 (86.5%) | 4 (7.7%) | 3 (5.8%) |
| Eczema* | 42 (65.6%) | 22 (34.4%) | 0 |
| AD | 25 (92.6%) | 1 (3.7%) | 1 (3.7%) |
| Drug-induced* | 8 (21.0%) | 29 (76.3%) | 1 (2.6%) |
| SS** | 22 (57.9%) | 3 (7.9%) | 13 (34.2%) |
| MF** | 12 (70.6%) | 0 | 5 (29.4%) |
| Miscellaneous | 17 (80.9%) | 3 (14.3%) | 1 (4.8%) |
| Idiopathic | 43 (82.7%) | 5 (9.6%) | 4 (7.7%) |
| Total | 214 (69.3%) | 67 (21.7%) | 28 (9.1%) |
*P < 0.001: higher remission rates in eczema and drug-induced erythroderma.
**P < 0.001: higher mortality rates in MF and SS.